Design and screening of a glial cell-specific, cell penetrating peptide for therapeutic applications in multiple sclerosis.
Multiple Sclerosis (MS) is an autoimmune, neurodegenerative disease of the central nervous system (CNS) characterized by demyelination through glial cell loss. Current and proposed therapeutic strategies to arrest demyelination and/or promote further remyelination include: (i) modulation of the host...
Guardado en:
Autores principales: | Corey Heffernan, Huseyin Sumer, Gilles J Guillemin, Ursula Manuelpillai, Paul J Verma |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d80d25d58d49422cbb3b596d5b5de789 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Photodynamic therapy by conjugation of cell-penetrating peptide with fluorochrome
por: Park CK, et al.
Publicado: (2017) -
Synthetic molecular evolution of hybrid cell penetrating peptides
por: W. Berkeley Kauffman, et al.
Publicado: (2018) -
Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis.
por: Yu Han Liu, et al.
Publicado: (2012) -
Contrasting roles for actin in the cellular uptake of cell penetrating peptide conjugates
por: L. He, et al.
Publicado: (2018) -
Synthesis and study of cell-penetrating peptide-modified gold nanoparticles
por: Boussoufi F, et al.
Publicado: (2018)